Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Infectious Diseases

• Publication date

  2013-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/cit655PMID 24065321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Centre for Disease Prevention and Control.

  2014cited by this paper
• Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.

  2012cited by this paper
• The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

  2012cited by this paper
• Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis.

  2012cited by this paper
• Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

  2012cited by this paper
• Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews.

  2012cited by this paper
• Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.

  2012cited by this paper
• Paediatric use of second-line anti-tuberculosis agents: a review.

  2012cited by this paper
• Global tuberculosis control 2010

  2012cited by this paper
• Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.

  2011cited by this paper
• Drug-resistant tuberculosis: pediatric guidelines.

  2011cited by this paper
• Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008.

  2011cited by this paper
• Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis.

  2010cited by this paper
• Management of drug-resistant tuberculosis.

  2010cited by this paper
• Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents

  2009cited by this paper
• Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort

  2009cited by this paper
• High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies.

  2009cited by this paper
• Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.

  2009cited by this paper
• Exposición a tuberculosis multirresistente: estudio y seguimiento de nueve niños

  2008cited by this paper
• Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda

  2008cited by this paper
• A Systematic Review of Pediatric Adherence to Antiretroviral Therapy in Low- and Middle-Income Countries

  2008cited by this paper
• [Exposure to multiresisant tuberculosis: study and follow-up of nine children].

  2008cited by this paper
• Management of Pediatric Multidrug-Resistant Tuberculosis and Latent Tuberculosis Infections in New York City From 1995 to 2003

  2008cited by this paper
• Failure of Chemoprophylaxis With Standard Antituberculosis Agents in Child Contacts of Multidrug-Resistant Tuberculosis Cases

  2007cited by this paper
• Guidance for National Tuberculosis Programmes on the management of tuberculosis in children - an update.

  2007cited by this paper
• Guidance for National Tuberculosis Programmes on the management of tuberculosis in children CHAPTER 1 IN THE SERIES

  2006cited by this paper
• Childhood pulmonary tuberculosis: old wisdom and new challenges.

  2006cited by this paper
• Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control

  2006cited by this paper
• Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis

  2006cited by this paper
• Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis.

  2006cited by this paper
• Health and related indicators

  2005cited by this paper
• South African Health Review 2005.

  2005cited by this paper
• Childhood tuberculosis: clinical research needs.

  2004cited by this paper
• The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

  2004cited by this paper
• Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting

  2004cited by this paper
• Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis

  2002cited by this paper
• Isoniazid for preventing tuberculosis in non-HIV infected persons.

  1999cited by this paper
• 1994 Red Book: Report of the Committee on Infectious Diseases

  1996cited by this paper
• Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.

  1996cited by this paper
• Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey.

  1994cited by this paper
• Management of persons exposed to multidrug-resistant tuberculosis.

  1992cited by this paper
• Report of the Committee on Infectious Diseases

  1989cited by this paper
• Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids

  1977cited by this paper
• Controlled chemoprophylaxis trials in tuberculosis. A general review.

  1970cited by this paper
• Controlled chemoprophylaxis trials in tuberculosis. A general review.

  1970cited by this paper

• HIV testing during systematic screening for tuberculosis among household contacts in high-tuberculosis burden settings: a systematic review and meta-analysis.

  2026cites this paper
• Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.

  2025cites this paper
• Acceptability of multidrug-resistant tuberculosis preventive treatment: a retrospective survey

  2025cites this paper
• Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

  2025cites this paper
• Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment

  2025cites this paper
• Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM

  2024cites this paper
• Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household

  2023cites this paper
• Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis

  2023cites this paper
• Pediatric multi-drug-resistant tuberculosis in Germany – diagnostic and therapeutic challenges of an “orphan disease”

  2023cites this paper
• Contact screening and management in a high-transmission MDR-TB setting in Papua New Guinea: Progress, challenges and future directions

  2023cites this paper
• Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children

  2023cites this paper
• High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis

  2022cites this paper
• Increasing tuberculosis preventive treatment (TPT) uptake in children

  2022cites this paper
• Caregiver willingness to give TPT to children living with drug-resistant TB patients

  2022cites this paper
• The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study

  2022cites this paper
• Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.

  2022cites this paper
• Preventive Therapy for Contacts of Drug-Resistant Tuberculosis

  2022cites this paper
• Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland

  2021cites this paper
• Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan

  2021cites this paper
• TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen.

  2020cites this paper
• Preventive Therapy for Multidrug Resistant Latent Tuberculosis Infection: An Ethical Imperative with Ethical Barriers to Implementation?

  2020cites this paper
• Prevention of community-acquired pneumonia in children: South African Thoracic Society guidelines (part 4)

  2020cites this paper
• When to start treatment? Dilemma illustrated by a paediatric case of extensively drug-resistant tuberculosis of the central nervous system.

  2020cites this paper
• Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children

  2020cites this paper
• Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study

  2020cites this paper
• Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines

  2020cites this paper
• Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.

  2020cites this paper
• Risk factors for adverse events in household contacts prescribed preventive treatment for drug-resistant TB exposure.

  2020cites this paper
• WHO EMRO | Multidrug-resistant disseminated tuberculosis in a 9-month-old infant

  2020cites this paper
• MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

  2020cites this paper
• Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial

  2020cites this paper
• Children and Mycobacterium tuberculosis : a review of susceptibility and protection

  2019cites this paper
• Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

  2019cites this paper
• Tuberculosis susceptibility and protection in children.

  2019cites this paper
• Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis

  2019cites this paper
• Exposed! Management of MDR-TB household contacts in an evidence light era.

  2019cites this paper
• Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar

  2019cites this paper
• Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs

  2019cites this paper
• Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia

  2019cites this paper
• Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.

  2019cites this paper
• The evolving research agenda for paediatric tuberculosis infection.

  2019cites this paper
• Tuberculosis in Children

  2019cites this paper
• Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)

  2018cites this paper
• Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis.

  2018cites this paper
• [Tuberculosis treatment for children: An update].

  2018cites this paper
• Treatment of Multidrug-resistant Tuberculosis Infection in Children

  2018cites this paper
• Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review

  2018cites this paper
• Treatment of tuberculosis infection in children

  2018cites this paper
• Treatment of Multidrug-Resistant Tuberculosis Infection in Children

  2018cites this paper
• High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study

  2018cites this paper
• Tuberculosis treatment for children: An update

  2018cites this paper
• Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children

  2018cites this paper
• Isoniazid preventive therapy protects against tuberculosis among household contacts of isoniazid-resistant patients

  2018cites this paper
• Preventive therapy for latent tuberculosis infection-the promise and the challenges.

  2017cites this paper
• Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.

  2017cites this paper
• [Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

  2017cites this paper
• S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter

  2017cites this paper
• Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis

  2017cites this paper
• Extensively Drug-resistant Tuberculosis (XDR-TB): A daunting challenge to the current End TB Strategy and policy recommendations.

  2017cites this paper
• Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis

  2017cites this paper
• Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

  2017cites this paper
• The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study

  2017cites this paper
• The management of infection with Mycobacterium tuberculosis in young children post-2015: an opportunity to close the policy-practice gap

  2017cites this paper
• Update on trends in childhood tuberculosis

  2017cites this paper
• Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.

  2017cites this paper
• Drug-Resistant tuberculosis - primary transmission and management.

  2017cites this paper
• Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.

  2017cites this paper
• Management of Tuberculosis in Special Populations

  2017cites this paper
• Treatment of Tuberculosis Infection in Children

  2017cites this paper
• Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.

  2016cites this paper
• Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.

  2016cites this paper
• Multidrug-Resistant Tuberculosis in Children: Recent Developments in Diagnosis, Treatment and Prevention

  2016cites this paper
• Miscellaneous Antibacterial Drugs

  2016cites this paper
• Multidrug-resistant disseminated tuberculosis in a 9-month-old infant.

  2016cites this paper
• Tuberculosis and pneumonia in HIV-infected children: an overview

  2016cites this paper
• Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda

  2016cites this paper
• Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China

  2016cites this paper
• Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis

  2016cites this paper
• TB and HIV co-infection in children: do we know enough?

  2016cites this paper
• Adverse effects of oral second-line antituberculosis drugs in children

  2016cites this paper
• Multidrug-Resistant Tuberculosis in Children: A Field Guide

  2015cites this paper
• Latent tuberculous infection: ethical considerations in formulating public health policy.

  2015cites this paper
• Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis

  2015cites this paper
• Latent Mycobacterium tuberculosis infection.

  2015cites this paper
• Fluoroquinolones for the treatment of tuberculosis in children.

  2015cites this paper
• Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.

  2015cites this paper
• High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo

  2015influential citation
• Tuberculosis in children - Need for urgent roadmap under Revised National Tuberculosis Control Programme.

  2015cites this paper
• Antituberculosis drugs in children

  2015cites this paper
• Getting it right for children: improving tuberculosis treatment access and new treatment options

  2015cites this paper
• Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children.

  2015cites this paper
• Enfants au contact d’individus atteints d’une tuberculose multi-résistante : quelles stratégies adopter ? Analyse de 46 enfants contacts et revue de la littérature

  2015cites this paper
• Chapter 26 – Miscellaneous Antibacterial Drugs

  2015cites this paper
• Paediatric chemoprophylaxis for child contacts of drug-resistant tuberculosis cases: Are current guidelines effective in preventing disease?

  2015cites this paper
• Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

  2015cites this paper
• Getting to 90-90-90 in paediatric HIV: What is needed?

  2015cites this paper
• Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis.

  2015cites this paper
• Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel

  2015cites this paper
• Paediatric chemoprophylaxis for child contacts of patients with drug-resistant tuberculosis: Are current guidelines effective in preventing disease?

  2015influential citation
• A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.

  2015cites this paper